These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 11502514)

  • 21. Pyloricidins, novel anti-helicobacterpylori antibiotics produced by Bacillus sp. I. Taxonomy, fermentation and biological activity.
    Nakao M; Miyagaw K; Nakano Y; Sakane T; Tada M; Nishimura O; Fujino M
    J Antibiot (Tokyo); 2001 Nov; 54(11):926-33. PubMed ID: 11827035
    [TBL] [Abstract][Full Text] [Related]  

  • 22. One-week ranitidine bismuth citrate in combinations with metronidazole, amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection: the RBC-MACH study.
    Sung JJ; Chan FK; Wu JC; Leung WK; Suen R; Ling TK; Lee YT; Cheng AF; Chung SC
    Aliment Pharmacol Ther; 1999 Aug; 13(8):1079-84. PubMed ID: 10468684
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Helicobacter pylori in children and adolescents: increase of primary clarithromycin resistance, 1997-2000.
    Crone J; Granditsch G; Huber WD; Binder C; Innerhofer A; Amann G; Hirschl AM
    J Pediatr Gastroenterol Nutr; 2003 Mar; 36(3):368-71. PubMed ID: 12604976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Interaction of drugs for eradication therapy against antibiotic-resistant strains of Helicobacter pylori.
    Gotoh A; Kawakami Y; Akamatsu T; Katsuyama T
    Microbiol Immunol; 1997; 41(11):865-9. PubMed ID: 9444328
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An update on anti-Helicobacter pylori treatment in children.
    Khurana R; Fischbach L; Chiba N; Veldhuyzen van Zanten S
    Can J Gastroenterol; 2005 Jul; 19(7):441-5. PubMed ID: 16010308
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment regimens for Helicobacter pylori infection in children: is in vitro susceptibility testing helpful?
    Faber J; Bar-Meir M; Rudensky B; Schlesinger Y; Rachman E; Benenson S; Sirota G; Stankiewic H; Halle D; Wilschanski M
    J Pediatr Gastroenterol Nutr; 2005 May; 40(5):571-4. PubMed ID: 15861018
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Helicobacter pylori resistance to antibiotics before and after treatment: Incidence of eradication failure.
    Nestegard O; Moayeri B; Halvorsen FA; Tønnesen T; Sørbye SW; Paulssen E; Johnsen KM; Goll R; Florholmen JR; Melby KK
    PLoS One; 2022; 17(4):e0265322. PubMed ID: 35442962
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activities of linezolid alone and in combination with amoxicillin, clarithromycin, and metronidazole against Helicobacter pylori.
    Hirschl AM; Apfalter P; Makristathis A; Rotter ML; Wimmer M
    Antimicrob Agents Chemother; 2000 Jul; 44(7):1977-9. PubMed ID: 10858365
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The relationship between consumption of antimicrobial agents and the prevalence of primary Helicobacter pylori resistance.
    Perez Aldana L; Kato M; Nakagawa S; Kawarasaki M; Nagasako T; Mizushima T; Oda H; Kodaira J; Shimizu Y; Komatsu Y; Zheng R; Takeda H; Sugiyama T; Asaka M
    Helicobacter; 2002 Oct; 7(5):306-9. PubMed ID: 12390210
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effectiveness of systemic eradication therapy against oral Helicobacter pylori.
    Bago I; Bago J; Plečko V; Aurer A; Majstorović K; Budimir A
    J Oral Pathol Med; 2011 May; 40(5):428-32. PubMed ID: 21198868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Antimicrobial activity and additive effect of the modified Gingyo-san with antimicrobials against Helicobacter pylori.
    Nakase K; Nakanishi-Yamasaki M; Harada K; Koizumi J; Yamada T; Ikoshi H; Nakaminami H; Noguchi N
    J Infect Chemother; 2021 Jul; 27(7):957-961. PubMed ID: 33602640
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibiotic resistance of Helicobacter pylori in pediatric patients -- 10 years' experience.
    Hojsak I; Kos T; Dumančić J; Mišak Z; Jadrešin O; Jaklin Kekez A; Lukić Grlić A; Kolaček S
    Eur J Pediatr; 2012 Sep; 171(9):1325-30. PubMed ID: 22430353
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibiotic resistance of Helicobacter pylori in the European part of the Russian Federation: first results].
    Maev IV; Andreev DN; Govorun VM; Ilina EN; Kucheryavyy YA; Oganesian TS; Melnikova EV; Zayratyants OV; Parfenova TV; Dzhedzheia LV; Kirillova NV; Maevskaya EA; Fomenko AK; Lobanova EG; Zaborovskii AV; Kriukov KA
    Ter Arkh; 2020 Sep; 92(8):24-28. PubMed ID: 33346458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of plaunotol in combination with clarithromycin against clarithromycin-resistant Helicobacter pylori in vitro and in vivo.
    Sasaki M; Mizoshita T; Mizushima T; Inoue H; Kamiya T; Kataoka H; Ogaswara N; Wada T; Kubota E; Mori Y; Shimura T; Hirata H; Ando K; Okamoto Y; Ohara H; Nakao H; Joh T
    J Antimicrob Chemother; 2007 Nov; 60(5):1060-3. PubMed ID: 17827146
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose lansoprazole and clarithromycin plus metronidazole vs. full-dose lansoprazole and clarithromycin plus amoxicillin for eradication of Helicobacter pylori infection.
    Bazzoli F; Zagari RM; Pozzato P; Fossi S; Ricciardiello L; Nicolini G; De Luca L; Berretti D; Alampi G; Di Pietro C; Morelli P; Roda E
    Aliment Pharmacol Ther; 2002 Jan; 16(1):153-8. PubMed ID: 11856090
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antimicrobial susceptibility tests and resistant strain of Helicobacter pylori].
    Wada S; Matsuda M; Shingaki M; Kai A; Takahashi S; Itoh T
    Kansenshogaku Zasshi; 2003 Apr; 77(4):187-94. PubMed ID: 12739371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Incidence of secondary Helicobacter pylori resistance to antibiotics in treatment failures after 1-week proton pump inhibitor-based triple therapies: a prospective study.
    Pilotto A; Franceschi M; Rassu M; Leandro G; Bozzola L; Furlan F; Di Mario F
    Dig Liver Dis; 2000 Nov; 32(8):667-72. PubMed ID: 11142574
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High percentage of clarithromycin and metronidazole resistance in Helicobacter pylori clinical isolates obtained from Spanish children.
    Agudo S; Alarcón T; Cibrelus L; Urruzuno P; Martínez MJ; López-Brea M
    Rev Esp Quimioter; 2009 Jun; 22(2):88-92. PubMed ID: 19544100
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Prevalence of Helicobacter pylori resistant to clarithromycin, amoxicillin and metronidazole in children].
    Chen J; Chen FB; Yu JD; Chen XJ; Li ZY; Zhang XP
    Zhonghua Er Ke Za Zhi; 2004 Oct; 42(10):769-71. PubMed ID: 16221349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of a 23S ribosomal RNA mutation in Helicobacter pylori strains on the in vitro synergistic effect of clarithromycin and amoxicillin.
    Sakinc T; Baars B; Wüppenhorst N; Kist M; Huebner J; Opferkuch W
    BMC Res Notes; 2012 Oct; 5():603. PubMed ID: 23110798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.